BRIC In Vitro Diagnostics (IVD) Market

1
MarketsandMarkets Presents
BRIC In Vitro Diagnostics (IVD) Market Forecast
to 2022
http//www.marketsandmarkets.com/Market-Reports/iv
d-bric-market-198.html
2
The report "BRIC IVD Market  by Product
Service (Instruments, Reagents, Software),
Technology (Immunoassay, Hematology,
Microbiology), Application (Diabetes, Cardiology,
Infectious Diseases), Country (Brazil, Russia,
India, China) - Forecast to 2022", The BRIC IVD
Market and other emerging countries is expected
to reach USD 15.71 Billion by 2022 from USD 10.60
Billion in 2017, at a CAGR of 8.2.   Browse 138
market data tables and 69 figures spread through
278 pages and in-depth TOC on "BRIC IVD Market
http//www.marketsandmarkets.com/Market-Reports/
ivd-bric-market-198.htmlEarly buyers will
receive 10 customization on this reports The
rising incidence of chronic diseases, growth in
the number of private diagnostic centers, and
rising consolidation of laboratories are the key
factors driving the market growth. However,
inadequate reimbursement and the slow growth of
the economy are the factors restraining the
growth of this market.
http//www.marketsandmarkets.com/Market-Reports/iv
d-bric-market-198.html
3
This research study involved the extensive use of
both primary and secondary data sources as well
as various factors affecting the industry,
including the regulatory landscape competitive
scenario historic data current trends in the
market technological innovations and upcoming
technologies and market drivers, restraints,
opportunities, and challenges. In this report,
the BRIC In Vitro Diagnostics (IVD) Market is
segmented by product service, technology,
application, end user, and country. Based on
application, the market is segmented into
diabetes, infectious diseases, oncology/cancer,
cardiology, HIV/AIDS, autoimmune diseases,
nephrology, drug testing/pharmacogenomics, and
others. The infectious diseases segment accounted
for the largest share of the market in 2016,
owing to the rising incidence of tuberculosis
(TB), hepatitis, and hospital-acquired infections.
http//www.marketsandmarkets.com/Market-Reports/iv
d-bric-market-198.html
4

Based on technology, the BRIC IVD Market is
broadly segmented into immunoassays/immunochemistr
y, clinical chemistry, molecular diagnostics,
hematology, clinical microbiology, coagulation
hemostasis, and other technologies. The molecular
diagnostics segment is estimated to register the
highest CAGR during the forecast period of 2017
to 2022. The Sample Report For This Report_at_
http//www.marketsandmarkets.com/requestsample.as
p?id198 The rising prevalence of infectious
diseases, cancer, and various genetic disorders
growing demand for blood screening and
increasing application of molecular diagnostic
technologies in pharmacogenetics and
point-of-care testing is expected to drive the
growth of the market during the forecast period.
http//www.marketsandmarkets.com/Market-Reports/iv
d-bric-market-198.html
5
Geographically, China dominated the BRIC IVD
Market and other emerging countries in 2016.
China is also expected to register the highest
CAGR, due to the growth in research activities
and increasing investments by leading players and
government agencies in the country. Get The PDF
Brochure For This Report_at_ http//www.marketsandma
rkets.com/pdfdownload.asp?id198 The key players
in this BRIC IVD Market are Roche Diagnostics
(Switzerland), Abbott Laboratories Inc. (U.S.),
Siemens Healthineers (Germany), Danaher
Corporation (U.S.), Thermo Fisher Scientific Inc.
(U.S.), Sysmex Corporation (Japan), Bio-Rad
Laboratories, Inc. (U.S.), bioMérieux (France),
and Becton, Dickinson and Company (U.S.), Johnson
Johnson (U.S.), QIAGEN N.V. (Germany),
Ortho-Clinical Diagnostics, Inc. (U.S.), and
Diasorin S.P.A. (Italy).  
http//www.marketsandmarkets.com/Market-Reports/iv
d-bric-market-198.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/iv
d-bric-market-198.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets